Posters

Clinical and patient reported outcomes after a cataract surgery with bilateral implantation of a monofocal intraocular lens with a refractive profile

Poster Details

First Author: J.Neri Miranda Pires PORTUGAL

Co Author(s): A. Vergamota   C. Marques   J. Baptista   J. Silva           

Abstract Details

Purpose:

To evaluate the clinical and patient-reported outcomes after phacoemulsification with bilateral implantation of a monofocal intraocular lens (IOL) – ICB00 Eyhance.

Setting:

Hospital dos Lusíadas Lisboa, Lisboa, Portugal

Methods:

A prospective, nonrandomized, comparative study, that included 31 patients (62 eyes), of which 20 where implanted bilaterally with ICB IOL after cataract surgery (group 1) and 11 with PCB00 (group 2). Distance, intermediate and near visual acuity (VA) were evaluated at 3 months postoperative of second eye surgery. Distance and near stereoacuity, contrast sensitivity and chromatic vision were also performed. Spectacle independence, photic phenomena, and visual satisfaction was assessed by a patient report questionnaire (PRO) aimed at evaluating outcomes of cataract surgery with distance, intermediate and near vision correction.

Results:

The cohort had a female predominance (60% [group 1] and 54,6% [group 2]) and a mean age of 68 years±7,7 [group 1] and 68,5±5,3 [group 2]). Percentage of patients with distance VA > 1,0 was 85% (group1) and 90,9% (group 2); intermediate VA >1,0 was 86,7% (group 1) and 54,5% (group 2), near VA > J2 was 70% (group 1) and 45,45% (group 2). Group 1 patients had higher spectacle independence in activities such as reading a newspaper and computer use, when compared with group 2 patients (45% vs 0% and 55% vs 36,3%, respectively).

Conclusions:

In conclusion, near and intermediate vision was statistically significantly better in group 1 patients.  PRO results showed that both patient-reported satisfaction and spectacle independence was higher in group 1. Furthermore, it allowed for objectively quantify the occurrence of dysphotopsias, and to qualify them in subtypes and regarding the level of discomfort induced.

Financial Disclosure:

None